Precipio has developed a proprietary hematologic malignancy screening panel. The screening panel currently includes JAK2 (V617F), JAK2 Exon 12 & 13, MPL & CALR. The panel utilizes a rapid and cost-effective mutation screening technology called High Resolution Melt analysis (HRM).
HemeScreen can be ordered separately, or will be included as part of the workup.
To place an order or request collection reagents, please call our customer service at 203.787.1717 or email at email@example.com